Journals / Turkish Journal of Urology / 2021 / Cilt: 47 - Sayı: 6

Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study

Pages
501–508
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Healthcare services and government spending should be organized according to these data.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to show the surgical trend over the past 14 years using the data from five major centers in Turkey with accumulated experience in benign prostatic hyperplasia (BPH) surgery.
📊
Key Findings & Data:Material and methods: This study included 94,954 patients with low urinary tract symptoms (LUTSs) secondary to BPH.
💡
Conclusion & Impact:Healthcare services and government spending should be organized according to these data.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: The aim of this study is to show the surgical trend over the past 14 years using the data from five major centers in Turkey with accumulated experience in benign prostatic hyperplasia (BPH) surgery. Material and methods: This study included 94,954 patients with low urinary tract symptoms (LUTSs) secondary to BPH. By using electronic databases, we identified 7,163 patients who underwent BPH surgery, including monopolar transurethral prostate resection (M-TURP), bipolar transurethral prostate resection (BTURP), transurethral incision of the prostate (TUIP), open prostatectomy (OP), and holmium laser enucleation of the prostate (HoLEP) from 2006 to 2019. The years were grouped as 2006-2010, 2011-2015, and 2016-2019. Results: The total number of outpatient treatments for BPH increased by 72.9% from 5,379 in 2006 to 9,302 in 2019. Until 2019, the annual number of surgeries increased from 375 to 937 (increasing 150%). All surgical approaches for BPH, except TUIP, were most frequently performed between the ages of 60 and 69. The rate of surgery including M-TURP, B-TURP, and TUIP was statistically different between 2006 and 2010, 2011 and 2015, and 2016 and 2019 (P < .001), except OP (P ¼ .071). The highest increase was observed in HoLEP in the first half of the 2010s compared to the second half of the 2010s. The rate of M-TURP decreased from 77.9% to 17.9% from 2016 to 2019. Conclusion: With the aging population, the number of patients diagnosed and treated with BPH is increasing. B-TURP as a resection technique and HoLEP as an enucleation technique replace M-TURP. Healthcare services and government spending should be organized according to these data.

🔖

Cite This Article

İBİŞ, M. A., ÇAYAN, S., TOKATLI, Z., ORHAN, İ., AŞCI, R., KOCAMANOĞLU, F., AKBAY, E., YAMAN, Ö. (2021). Trends in benign prostatic hyperplasia surgery over the years: A multicenter 14-year retrospective study. Turkish Journal of Urology, Cilt: 47 - Sayı: 6, 501–508. https://ajindex.com/articles/404222

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: Benign prostatic hyperplasia. J Urol. 2005
  2. 173(4):1256- 1261. [CrossRef] 2. Gravas S, Cornu J, Drake M, et al. EAU Guidelines on Non- Neurogenic Male LUTS Including Benign Prostatic Obstruction. Arnhem: European Association of Urology, 2019. 3. Welliver C, Feinstein L, Ward JB, et al. Trends in lower urinary tract symptoms associated with benign prostatic hyperplasia, 2004 to 2013: The urologic diseases in America project. J Urol. 2020
  3. 203(1):171-178. [CrossRef] 4. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)—Incidence, management, and prevention. Eur Urol. 2006
  4. 50(5):969-980. [CrossRef] 5. Naspro R, Manica M, Meneghini A, et al. From “gold standard” resection to reproducible “future standard” endoscopic enucleation of the prostate: What we know about anatomical enucleation. Minerva Urol Nefrol. 2017
  5. 69(5):446-458. 6. Institute TS. About Turkeys’ aging rates. 2020. Available at https://data.tuik.gov.tr/. 7. Gravas S, Bach T, Drake M, et al. EAU Guidelines on Non- Neurogenic Male LUTS Including Benign Prostatic Obstruction. Arnhem: European Association of Urology, 2017. 8. Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol. 2000
  6. 163(2):490-495. [CrossRef] 9. Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin. 2016
  7. 43(3):289-297. [CrossRef] 10. Patel RM, Bariol S. National trends in surgical therapy for benign prostatic hyperplasia in Australia. ANZ J Surg. 2019
  8. 89(4):345- 349. [CrossRef] 11. Yu X, Elliott SP, Wilt TJ, McBean AM. Practice patterns in benign prostatic hyperplasia surgical therapy: The dramatic increase in minimally invasive technologies. J Urol. 2008
  9. 180(1):241-245. [CrossRef] 12. Jeon BJ, Chung H, Bae JH, Jung H, Lee JG, Choi H. Analysis of present status for surgery of benign prostatic hyperplasia in Korea using nationwide healthcare system data. Int Neurourol J. 2019
  10. 23(1):22. [CrossRef] 13. Neyer M, Reissigl A, Schwab C, et al. Bipolar versus monopolar transurethral resection of the prostate: results of a comparative, prospective bicenter study–perioperative outcome and long-term efficacy. Urol Int. 2013
  11. 90(1):62-67. [CrossRef] 14. Fagerstro¨m T, Nyman CR, Hahn RG. Complications and clinical outcome 18 months